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IN'rRODUCTION 
Selenium exhibits unusual biological properties in that it is 
a micro nutrient for animals (1) and some plants (2) and yet at 
slightly higher levels it may be very toxic (3,4). Neither the 
active forms of selenium nor the mechanisms by which its biological 
effects are produced are well understood. Thus, many aspects remain 
to be investigated in this area. 
Historically, early settlers in South Dakota were concerned 
with livestock losses from 1'alkali diseaserr which afflicted animals 
in many areas of the state. The condition was characterized by loss 
of hair and deformation or sloughing of the hoofs in cattle, hogs, 
and horses that consumed certain local forages a.nd grains (4, p. 4). 
Madison (5) had reported alkali disease as early as 1860 at Fort 
Randall, in an area now in South Dakota., where cavalry horses were 
affected. It is possible that Marco Polo (6) may even have been de­
scribing alkali disease when he wrote of his travels in Asia about 
1295 and about a poisonous plant which had the effect of causing the 
hoofs of the animals to drop off when they consumed it. In Wyoming 
a serious loss of livestock was associated with a form of forage 
poisoning which, because of the symptoms observed, was given the 
name "blind staggers'' ( 7) .  The afflicted animals wandered aimlessly 
in circles disregarding objects in their paths. Cattle might show 
no outward sign of poisoning, but suddenly develop symptoms which 
culminated in death within a few days (8). 
Franke (9), while working with the affected grain at 
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South Dakota State College, produced the toxic symptoms experimentally. 
Following the discovery by Robinson (10) of selenium in toxic 
wheat, Franke and Potter (11) demonstrated that the signs produced 
by inorganic selenium were identical to those of the toxic forages 
and grains. Franke (12) further deduced that plants incorporate 
soil selenium since the toxicity occurred in areas of high soil 
selenium. Beath and coworkers (8) in Wyoming reported that 
blind staggers was a form of selenium poisoning which occurred 
when animals consumed selenium-accumulating vetch plants. These 
plants contained as much as several thousand parts per million 
of selenium when grown on seleniferous soils (4, p. 5). 
Evidence is now accumulating that selenium. has a nutrient role 
in animals and in some plants. The requirement is not adequately de­
fined but various- investigators have shown that selenium can correct 
certain diseases. It has been reported by Patterson, Melstrey, and 
Stokstad (13) and Schwarz, Bieri,_Briggs, and Scott (14) to  be 
effective for preventing exudative diathesis in chicks when in­
cluded in diets at very low levels. Various investigators 
have reported its effectiveness against white muscle disease 
in lambs and calves (15). Other workers have shown that selenium 
supplementation gives a definite growth response under certain 
conditions (16). In plants, traces of inorganic selenium have been 
shown essential for normal growth of a number of Astragalus species 
(2) . Whether it is essential at very low concentrations for other 
plants is still unknown. The metabolic functions of this element at 
levels where it mediates a nutrient function as contrasted with the 
levels where it causes a toxic response are not understood. 
From the_ time selenium was first studied as a toxicant it was 
believed to have metabolic properties similar to sulfur since the 
elements have very similar chemical and physical properties. It 
was at first thought that selenium toxicity was primarily manifested 
by an interference with-sulfur metabolism (17'). This assumption 
gained acceptance from observations that linked the occurrence of 
selenium with sul:f\lr in biological compounds, and from the competitive 
interaction observed between sulfur a.nd selenium analogues in 
biological systems. Hurd-Karrer (18) demonstrated a selenate and 
sulfate antagonism by showing that sulfate reversed selenate in­
hibition of wheat plants. Fels and Cheldelin (19) reported a similar 
effect for both sulfate and methionine with the yeast, Saccharomyces 
.£_erevisiae . 
Other work has supported the.idea that sulf'ur A.Ild selenium are 
interchangeable in biological reactions� It has been shown that se­
lenitnn analogues may substitute for sulfur metabolites as substrates 
in enzymatic reactions. For example, the incorporation of seleno­
methionine into pancreatic juice protein does not alter the function 
o� the protein (20) . Also, selenium, as selenocystine, has been 
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detected as a constituent of protein in a number of instances (17). 
Therefore, the possibility of a partial substitution of selenium 
for sulfur in protein is apparent. 
Evidence also exists that selenium undergoes reactions within 
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the animal which are different from the metabolic pathways of sulfur 
metabolism. It has been postulated that selenium will form linkages 
between two sulfhydryl groups (21). Wool fibers which had been 
weakened by the· reduction of cystine cross-lin�ages to cysteine 
residues could be restrengthened by treatment with selenious acid (22). 
The result was apparent formation of selenium-containing cross­
linkages with each selenium atom linking two cysteine residues. Com­
pounds of this type that are known to be formed from simple sulfhydryl 
compounds include selenodiglutathione (23) and possibly selenodicys­
teine (24). 
The assumption that selenium toxicity in animals involves 
interference with sulfur activation reactions has not been proven 
by recent studies. In vivo studies by Halverson, Hills, and Whitehead 
{25) have shown that selenite-Se neither interferes with nor sub­
stitutes in the synthesis of chondroitin sulfate and taurine in chick 
embryos. Earlier work of Wilson and Bandurski (26) had suggested such 
an interference because of their observation that selenate undergoes 
some reactions similar to that of sulfate in the sulfate-activation 
sequence. 
One clue to the na.ture of selenium reactions vithin the animal 
is displayed by the exhalation of dimethyl selenide during selenium 
toxicity. The product is formed from injected (27) forms of selenium, 
and under some conditions is a major route of selenium exc�etion in 
animals which receive acute or subacute doses of selenium (28) . 
Microorganisms can also produce dimethylaelenide (29) and cereal 
grains have been reported to lose some of their original selenium 
while in storage during a 3 to 5 yeax period (30). 
The relation of the �ross abnormalities of selenium toxicity 
to selenium metabolism has not been adequately investigated. Liver 
damage, heart and spleen hypertrophy, edema., anemia, bilirubinuria, 
and jaundice are common symptoms of the toxicity in e.nir.ials such as 
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the rat. The liver abnonnalities involve various degrees of cirrhosis, 
necrosis, and atrophy ( li, p. 195). The liver rnetaboli sm has been 
investigated to some degree by Klug, oxon, and Petersen (31) with 
rats, and the anemia. has been investi�a.ted by Brown (32) in sheep 
affected by an anemia associated with ap .arent selenium toxicity. 
Klug et a�. showed that levels of succinic dehydro _,enase vere lowered 
in the livers of selenized rats. _Drown determined that red blood cell 
fragility is increased and red blood cell methemoglobin reductase is 
decreased with the toxicity in sheep. He worked with sheep subjected 
to long-term selenium poisoning and it is reco nized that his ob­
servations may not be directly applicable to the initial cause of the 
poisoning. 
This study was undertaken to observe the effects of a short term, 
toxic selenium treatment of rats on the concentration of certain 
tissue and urine components, specifically the lipids and amino acids. 
It was possible that the effects observed would help in establishing 
the specific metabolic abnormalities of selenium toxicity. 
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MATERIALS AND METHODS 
Methods of Animal Usage for the Metabolic Studies 
Female albino rats weighing 170 to 190 grams each were used for 
the studies. They were obtained from Sprague-Dawley, Inc. at a 
weight of 135 to 150 grams and fed Purina Laboratory Chow (Ralston 
Purina, Co. ) about 10 days. They were then divided in two groups of 
5 to 7 animals each, with each group having approximately equal 
average weights. They were placed in stainless steel metabolism 
cages with two animals of the same treatment ordinarily housed in 
each cage. During an ensuing 4-day period, the animals were force­
fed Nutrico (Nutritional Biochemicals, Corp. ), a liquid diet con­
taining 50 percent of solids. The feeding procedure consisted of 
giving each animal 7. 5 grams of the diet solids per day by means of 
stomach-tube feeding. The stomach tube_, which was O. 067 inch in 
outside diameter, was inserted at each feeding. The diet was fed 
3 times per day i� �-5 gram portions at 8:00 AM, 1:00 PM, and 4:30 PM. 
Tap water was fed free-choice. 
In the treated group each animal was given a daily intra­
peritoneal injection of 0. 141 miliigrams of selenium as sodium 
selenite during a 4-day period. Control animals were injected 
similarly with distilled water. The injection of selenium amounted 
to about 0.8 milligrams of the selenium per kilogram of animal 
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weight per day. The volume o� the individual doses was 0. 5 milliliter. 
Urine was collected from the .animals for 24-hour periods which 
began just before the daily injections. Samples from either the 
third or the fourth 24-hour period were retained for analysis. To 
preserve the urine the collection flasks were cooled with ice or 
dry ice and contained 1 milliliter of toluene per flask. If the 
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urine was contaminated with fecal matter the samples were not retained. 
At the completion of the fourth post-injection interval the 
animals were used for blood and liver sampling. To obtain the blood, 
they were anesthetized with ether, the abdominal vena cava was 
exposed, and about 5 milliliters of blood were withdrawn per animal 
by means of a hypodermic syringe. The blood was cooled immediately. 
The animals ordinarily died during the blood sampling. Their 
livers were quickly removed, weighed, and placed under freezing 
conditions. The spleens were also removed and weighed but they were 
not retained for analysis . To help insure uniform sampling of the 
treated and control groups of an experiment, the sampling between 
groups was alternated. 
To obtain the plasma the cold blood was centrifuged for 20 
minutes at 2000 rpm and the plasma was drawn off with a Pasteur 
disposable pipette. The plasma was recentrifuged for five minutes 
at a high speed setting in a clinical centrifuge, dra-wn off and, 
together with the liver samples, stored at -20° C until time of 
analysis. The plasma samples were composites of blood from three or 
four animals. The liver samples were composites for two animals in 
the case of the lipid analysis, and individual livers were used in 
the case of amino acid analysis. Urine samples were composites 
from two animals. 
Evaluation of the Selenium Toxicity Treatment Involved with 
Animal Usage 
Forty female albino rats weighing 170 to 190 grams each were 
obtained as described for the metabolic studies. The general 
procedure used in this part of the work is given in Table 1. Groups 
a and b with 8 rats per group were force-fed a liquid diet, injected, 
and sacrificed as described on pages 7 and 8 of this text. Group c, 
which consisted of 4 animals, was fed a purified dry diet by 
conventional means but the intake was restricted. They received 7. 5 
grams of diet in three - 2.5 gram portions which corresponded to the 
quantity of diet force-fed to groups a and b. Groups d and e with 
4 rats in each gr�up were also fed by conventional means. Group d 
animals, which received selenite-Se injections daily, were fed diet 
ad libitum. Group e animals received distilled water injections and 
were pair fed to the food intake of group d animals. 
The animals of groups a, b, c, d, and e were killed at the end 
of the 4-day treatment period and their livers and spleens were 
removed and weighed. The liver and spleen weights were converted 
to grams per 100 grams of body weight. Other animals (groups d20 days 
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Number ot 
Group animal• 
al 8 
bl 8 
C 4 
d 4 
e 4 
¾oc1qa 
4 
e20 dqa 4 
Table 1. Experilaental Casditions and Reau1ta ot Evaluation Stud;, 
Diet and method of feeding 
liqtd.d, fore�ted 
liquid, force-fed 
purl.tied dry, 1.s g/rat/day' 
purified dry, IS. l1bJ.t.3 
puritied dry, pair f'ed 
with 4 group 
puritied c1ry, Id. 11p1g 
purified dJ7, e. l3J?iiBJR 
after rourth dq 
Injections 
received 
water 
selenite-Se 
none 
selenite-Se 
water 
aelen1te-.5e 
water 
Treatment Average liver Average spleen 
period 
(dqa) 
4 
4 
4 
4 
4 
20 
. 20, 
weieta we15?!ta 
(em!LlOO grams bo<lT we!&htl 
3.62 0.28 
5.24 0.32 
).21 0.-28 
4.98 0.27 
2.98 0.24 
3-78 0.25 
,.19 0.12 
1Liver aid plaama samples used tor amino acid analysts. 
b 
and e20 days with 4 animals per group) were fed and handled as 
groups d and e except they were then continued on experiment 
under ad libitum feeding conditions for an additional 16 days. 
Their body weight changes and final liver and spleen weights 
were also observed. 
The rats in all groups were weighed daily. They were housed 
in stainless steel metabolism cages and fed tap water free-choice. 
The purified dry diet which was used contained 69.8% glucose, 
20% casein, 4% salt (33), 4% Mazola corn oil, and 2. 2% Vitamin 
Diet Fortification Mixture (Nutritional Biochemicals, Corp.). 
Lipid Analysis of Liver and Plasma 
Lipid was extracted from livers and plasma SM!.ples according 
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to the procedure described by Folch, Lees, and Sloane Stanley (34). 
The extracts were taken to dryness on a_rotary flash evaporator and 
the lipid residues were taken up in a known volume of the chloroform: 
methanol solvent �u�h that 20 milliliters of this solution was exactly 
equivalent to 1 gram of original liver or 1 milliliter of original 
plasma. For estimation of the total lipid matter of the chloroform: 
methanol solution an aliquot 5-milliliter portion was transferred 
into a tared vial, taken to dryness in a desiccator under partial 
vacuum, and weighed on a Mettler micro balance. Following the 
weighing, the samples were dissolved in a ·known volume of re­
distilled chloroform to give a solution that contained 5 to 10 
micrograms of lipid per microliter. These solutions were used 
for quantitative lipid determinations by thin-layer chromatog­
raphy. 
The lipid was separated into five classes by thin-layer 
chromatography according to the procedure of Blank, Schmit, and 
Privett (35). The adsorbent used was Silica Gel G (Brinkman 
Instruments, Inc. ) • It was spread onto the 20 x 20 centimeter 
chromatoplates with the Desaga/Brinkman applicator Model S-11. 
Nine lipid samples were generally applied to each plate using a 
Hamilton 50-microliter syringe. These spot applications, which 
were 5 0  to 200 micrograms of lipid each, were placed two centimeters 
apart and one and one-half centimeters from the bottom of the 
plate. The plates had three spots from each of treated and control 
samples of a given experimental trial, and three spots of a standard 
solution. The sample spots on a plate all contained the same total 
weight of lipid, and the standard spots contained three weight 
levels which were usually 10, 15, -and 20 micrograms. The standards 
used were cholesterol oleate, triolein, oleic acid (Applied Science 
Laboratories, Inc.), and cholesterol (Nutritional Biochemicals, 
Corp.). After the chromatogram was developed, it was heated for 
twenty minutes over a Lindberg Model H-2 hot plate set on high heat. 
The chromatoplate was about 3 millimeters from the hot surface, 
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being supported by a coarse mesh screen such as that used in 
drying ovens. It was removed from the hot plate and immediately 
sprayed lightly with a saturated solution of potassium dichromate 
in 70% by volume of aqueous sulfuric acid. The acid was sprayed 
under a hood with an Aersol Chromatography Spray Gun (Brinkman 
Instruments, Inc. ). The lipids appeared immediately as dark spots 
on a light background. 
The quantity of lipid in each spot on the chromatogram was 
determined by a method of reflectometry developed by John R. Romans 
(36). Reflectance measurements were made with a Photovolt Model 610 
photoelectric reflection meter equipped with an external mirror 
galvanometer for greater sensitivity. The galvanometer was ad­
justed to record 100% reflectance when the search unit of the meter, 
fitted with a green tristimulus filter, was placed on an area of 
the adsorbent containing no lipid spot. Reflectance readings were 
then made at each spot on the chromatogram. Standard curves for 
each lipid class were prepared by plotting the micrograms of lipid 
standard applied to the chromatogram versus the optical density as 
calculated from the r�flectance re�dings. The quantity of lipid 
in a sample was determined using the standard curve. Results were 
reported as the average of the three samples on the plate. A 
short study on reproducibility of the results obtained with this 
procedure is given in the Appendix. 
1.89379 
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Four major classes of lipid were quantitatively measured 
with this method; they were triglycerides, free fatty acids, 
cholesterol, and cholesterol esters. The phospholipids which re­
mained at the point of application on the plate were estimated by 
difference because reflectometry of a spot on the origin does not 
give reliable results (35). 
Analysis of Free Amino Acids in Liver, Plasma, and Urine 
The free amino acids of liver, plasma, and urine from the con­
trol and treated rats were separated and quantitated on the Beckman 
Model 120B amino acid analyser using the method of Moore, Spackman, 
and Stein (37). The acidic and neutral amino acids were chromato­
graphed on a 150 centimeter column using Beckman Resin Type 150A. 
The column temperature was 30° C for the first 11 hours of 
chromatography and 50° C for the remain�er of the separation. The 
basic amino acids were separated on a 50 centimeter column with 
Beckman Resin Typ� 50A at the same temperatures as described above. 
Liver, plasma, and urine samples were prepared as described 
by Moore, Stein, and Tallam (38, 39, 40) using 2. 5 grams, 5-10 
milliliters, and 10 milliliters,  respectively. The chromatographed 
samples were equivalent to 0. 5 grams, 2-4 milliliters, and 2 milli­
liters of the original liver, plasma, and urine. 
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RESULTS 
General Effects of Selenium Toxicity Treatment 
Weight responses of the control and treated animals described in 
Table 1 are shown in Figure I. The force-fed animals (lines a and b) 
suffered some weight loss during the first two days of the ex­
periment but maintained their weight thereafter. Weight losses were 
independent of the selenium injections. A similar weight loss was 
observed if control animals consumed the same a.mount of diet by 
conventional means (line c). The effect of allowing treated animals 
to consume feed ad libitum is shown in line d. These animals had no------
ticeable weight loss accompanied by low feed intake for a period 
extending to 7 days. After this time a steady weight recovery was 
observed as feed consumption increased. · The weight responses of 
control animals (line e) paralleled that of treated animals when 
the feed intake was similar. However, placing the control animals 
(e20 days ) on a� libitum feeding caused a rapid growth disparity to 
develop between them and the treated animals. 
The changes in organ and body weights and the mortality of 
the animals used for the metabolic studies are shown in Table 2. 
The livers of treated animals were about 25% larger than the livers 
of control animals. The 4-day treatment did not cause spleen en­
largement. Treated animals, which were fed by conventional means, 
also showed the same responses (Table 1, groups d and e). However, 
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A a . Cont rol , forc e- fed , 7 .  5,g/rat / day 
:\ b . Treated , force- fe d , 7 - 5g/rat / day 
x c . Control , convent i onal , 1 � 5g /rat /day 
o d . Treated , convent ional , ad l i.bi tum 
O P. . Control , pair fed to gr·o�p-d for 4 day s  
then fed a d  l ibitum 
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Table 2. Treatment Ett•cts Obtained in Metabolic Studies 
lumber ot Humber 
Trial animal ., survivors 
UDk91, trea:t!4 
11,2 lA 6 7 
n1•2 l4 6 1 
III 10 l 2 
rv1,2 10 3 3 
vl 10 4 s 
Av•rage-s 12 4 5 
Change or average 
bod1° weight duising 
treataent 
l,rwl 
co!fal treat«! 
..-13 -7 
� -17 
·-9 -1 
-20 -19 
-13 -9 
-1s -n 
1t1ver and plasma samples used tor lipid amJ.Tsie. 
2
uver and pluma aaaples uaed tor amino acid amJ.Tais. 
Average liv.r Average spleen 
ill •!Ill!:• ?!!!et• 
(grau/100 gram.a bod;f weight) 
goat.ml �nt!:!9 control tn,.teS 
1.11 1+.1s 0.29 , 0.28 
:,.19 4.19 o.,s O.Y/ 
2.99. 4.23 0.23 0.19 
3.13 4.19 0.26 0.25 
).46 4.39 0.23 o • .28 .  
,.is 4.23 0.28 0.27 
� 
the responses differed somewhat from those obtained if the 
treatment was continued for as long as 20 days. 'rhese animals had 
some liver enlargement and, in addition , had noticeable en­
largement of the spleen (Table 1 ,  groups d20 days and e20 days ) .  
Mortality during the 4-day experiment was apparently not an 
effect of the selenium treatment as similar deaths occurred in 
both treated and control groups. In an extended observation, 
however, one of the four treated animals which was fed by con­
ventional means ( Table 1, group d20 days) died after seven days , 
thus indicating that the treatment vas moderately severe. 
Effects of Treatment on Lipid of Liver and Plasma 
The lipid content of the livers and plasma of the animals fol­
lowing the treatment is shown in Table 3 �  Livers of treated 
animals had a higher percentage of lipid.in all trials. They con­
tained an average of 7. 47 grams of lipid per 100 grams of wet 
tissue while liver� of control animals contained an average of 5. 59 
grams of lipid per 100 grams of tissue. The quantity of lipid in 
the blood plasma was elevated by the treatment an average of 26% 
( 3-49%) in four trials. It was decreased in the fi�h trial by 8%. 
The averages were 327 and 383 milligrams of lipid per 100 milli­
liters of plasma for the control and treated groups � respectively. 
The analysis of the lipid components (Table 4)  showed that 
the percent of free fatty acids in the liver lipid increased an 
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Trial 
I 
II 
III 
IV 
V 
Table 3. Total Lipid Content of Liver and Plasma 
Liver 
(g lipid/ 100 g tissue) 
control treated 
6. 50 7 . 48 
2 . 45 6. 30 
5 . 83 8 . 44 
7 . 40 8. 29 
5. 80 6. 85 
Plasma 
(mg lipid/ 100 ml 
control 
309 
318 
325 
300 
381 
Averages 5 . 59 7 . 47 327 
19 
plasma) 
treated 
319 
292 
486 
385 
. 434 
383 
Liver 
Free Fatty Acids 
Tri&J¥cerides 
Free Cholesterol 
Cholesterol Esters 
Phoapholipida 
Plasma 
Fre� Fatty Acids 
Trigly'cerides 
Free Cholesterol 
Cholesterol Esters 
Phosphollpids 
Table 4 .  Lipid Canponents of Liv•r and Plana 
I 
10.2 
6.9 
12.6 
1.2 
69.l 
9. 5 
5.2 
s .o 
Control Treated 
(miero,mm• Eer 100 micrognm• total lif!dl 
Trial Trial 
II III IV Average I II III 
5.s ).9 2.1 5.5 12.1 6.0 4.1 
3.4 s.1 9.3 6.2 5.9 3.3 6.1 
lA.6 11.2 6 •. 2. 11.1 13.l JA..3 10.8 
1.1a. 1 .0  o.6 1.1 2.2 0.7 1. 5 
74.8 78.S 81.8 76.l 66.7 76.7 77.; 
6.0 4.8 s .4 6.4 15.0 4.2 5.7 
1. 5  4.2 6.6 4.4. 6.0 1..4 4.2 
10.0 i,.o 12.0 10.0 9.0 12.5 12.5 
IV 
5.2 
8.2 
1,.7 
o.s 
79.1 
6.5  
9.1 
lk.7 
10.7  18.6 21.0 34.9 21.)  12 .• 2 17.0 31.0 · 30.l 
69.6 63.9 s1.o 1.1.1 57.9 57.8 64.9 46.6 39.6 
Average 
6.8 
5.9 
ll.2 
1.3 
75.0 
7.8 
5.2 
12.2 
22.s 
52.2 
N 
0 
average of 44% due to treatment , the individual increases in the 
4 trails being 18%, 3%, 5% , and 150%. In the plasma the percent 
of free fatty acids increased in three of the four experimental 
trials due to treatment, and the percent of phospholipid 
decreased in three of the four trials. The percent of 
triglyceride , cholesterol, and cholesterol esters did not 
appear to be noticeably altered by the treatment in either liver 
or plasma lipid. 
Effect 9f Treatment .Q.,� Amino �cid Levels i� Liver , Plasma , 
a.nd Urine 
Table 5 presents data for the amino acid composition o� 
liver , plasma, and urine of the experimental animals . Each value 
represents the mean of four trials except where indicated. The 
standard errors of the means are shown in the table . Numerous amino 
acids showed change f'rom treatment within one trial but not in other 
trials . Frequently a considerable difference in the average values 
occurred but with the incons istencies observed between trials the 
standard errors showed no significant differences from treatment . 
Values are underlined where the treatment sample mean varied 40% 
or more from the control mean and when the change from the control 
vas consistent in each trial. Starred ( * )  values are those where 
means differ 40% or more, but changes were not consistent in all 
trials. 
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Table 5. Amino Acids and Related Compounds of Liver , Plasma , and Urine 
of Control and Selenite-Injected Rats 
Liver Plasma Urine 
(uM/g) (uM/100 ml ) ( uM/rat/24 hours ) --
control treated control treated control treated 
Total uMoles 
( without urea) 39 . 06± 
+ 
I 41 . 18- 258. 91± 251 . 57± 75 . 57:!: 87 . 33± 
6 . 81 · 10 . 00 46 . 93 49 . 79 19 . 01 18 . 17 
Amino acids 
4 . 74! 3 . 01:!: 3 . 49:!: Alanine 4 . 43:!: 21. 70± 25 . 30± 
o. 49 o . 84 2 . 95 2 . 73 0 . 22 0 . 73 
0 . 14! 0 . 16:!: + 1 . 41! B-Alanine 1 . 43-1 
0 . 04 0 . 03 0 . 23 0 . 39 
Arginine + 7. 87- 5 . 30� 
+ o . 84- + 1 . 00-
1. 24_ 1 . 23 0 . 09 0. 23 
Asparagine and 
+ 
4 . 64:!: 41. 55! 2 8. 39! 1 . 95! 
+ 
Glutamine 4 . 07- 3 . 20-
0 . 28 1 . 26 7 . 47 2 . 18 0 . 09 o . 44-
Aspartic + 1 . 46! 0 . 96±1 0 . 92± 0 . 60 
3 * 0 . 30 3 1 . 35-
0 . 20 0 . 24 0 . 27 0 . 31 l 
Citrulline + * 15 . 51±1 0 . 50 
3 * o·. 85 3 9. 12-2 6 . 12 6 . 83 
I\) 
I\) 
Liver 
(uM/g) 
control treated 
Cystine + 1. 01- 1. 75! 
0. 26 0 . 81 
Glutamic acid 3. 24! 2. 66:!: 
0. 56 0. 58 
Glycine 2. 91! * 
+ 
4. 25-
0. 18 1. 00 
Histidine + 0. 39- + 0. 39-
0. 03 0. 10 
1-Methylhistidine 
3�Methylhistidine 
Isoleucine 0. 29:!: * o. 49! 
0. 06 0 . 22 
Leucine o. 6� + o . 88-
0. 16 0. 25 
Lysine 1. 10! 
+ o . 87-
0. 14 0. 18 
Plasma 
(uM/ 100 ml) 
control treated 
11. 78� + 7. 35-1 
2 . 34 0 . 95 
+ 
6. 41- * 9 . 25:!: 
2. 13 1. 67 
17. 58± 14. 45! 
2 . 89 3 . 35 
+ 2 . 61-
+ 2 . 57-
1 . 46 0 . 34 
3. 48'! 3. 58! 
0. 94 0 •. 75 
5 . 62! 6 . 42'.!: 
1. 01 1. 11 
+ 25. 20- 29 . 04! 
3. 16 6. 53 
Urine 
( uM/rat/24 hours) 
control treated 
3. 36:!: 1. 84± 
o . 66- 0. 85 
+ 1. 67- 3. 04� 
0. 09 .9. 19 
+ 
4. 45-
+ 4 . 92-
0. 34 0. 23 
+ + 1 . 55- 3 . 20-
.Q_. 05 9. 16 
+ 0 • .39- 0. 97! 
0. 12 0 . 21 
+ 
0. 32-
+ 0. 72-
0. 06 0. 16 
+ 
0. 51- + 0. 60-
0. 04 0. 09 
+ + o . 69- 1. 00---
_Q_. 05 0 . 1� 
+ 
2 . 37- 4 . 74-
o .41 0. 93 
t\) w 
control 
Methionine 0. 22! 
0 . 04 
Ornithine 
+ 
0 . 55-
0 . 12 
Phenylalanine 0 . 26! 
0 . 05 
Proline o . 49± 
0 . 16 
Serine 2 . 08:!: 
0 . 25 
Threonine 
+ 
1. 16-
0 . 20 
Tryptophan 
Tyrosine 
+ 
0 . 38-
0. 05 
+ 
Va.line o . 47-
0 . 24 
Liver Plasma 
( uM/g) (uM/100 ml ) 
treated · control treated 
* 0 . 35! 
0 . 16 
o . 4o± 
0 . 08 
'* o . 47! 
0 . 21 
0 . 6o:t1 0 . 32 
2 . 55:!: 
0 . 71 
1 . 31:!: 
0 . 32 
+ o . 44-
0. 19 
0 . 16:!: 
* 0 . 17 
1 . 96! 
0 . 35 
+ 
2 . 70-
0 . 13 
2 . 70! 
0 . 28 
5 . 71± 
2 . 06 
' + 24 . 57-
2 . 89 
11 . 67:!: 
0 . 80 
+ 1. 90-
0. 72 l 
+ 2 . 90-
0 . 33 
+ 
1 . 41-
0 . 07 
+ 
2 . 40-
0 . 53 
5 . 03:!: 
1 . 11 
+ 
2 . 92-
0 . 37 
7 . 44� 
1 . 09 
+ 
23 . 61-
3 . 41 
+ 
9 . 17-
2. 81 
+ 
1 . 34-2 
0 .. 16 
+ 
3 . 01-
o . 49 
0 . 75! 
0. 18 
Urine 
{Ul�/rat/24 hours ) 
control treated 
..-6+ 2 . b  - + 2 . 92-
0 . 26 0 . 50 
+ 
.9. 11-. o . 60� 
0 . 03 .Q . 13 
+ 0 . 10- + 0 . 11-
0 . 05 0 . 13 
1 . 22± 1 . 73± 
0. 19 0 . 34 
+ 
2 . 81- 3 . 30± 
0 . 15 0 . 72 
+ 2 . 44- + l!Jl-
0 . 12 0 . 37 
1 . 79:!: + 1 . 86-
0 . 05 0 . 30 
+ + 0 . 59- 0 . 57-
0 . 13 l 0 . 14 
I\) � 
Liver 
( u.M/g) 
control 
Related compounds 
Ammonia 
Creatinine 
Ethanolamine 
Phosphoethanole.mine 
Taurine 
Urea 
Unknovn 
7 . 74! 
0 . 97 
1 . 23! 
0 . 38 
2 . 81:!: 
1 . 04 
0 . 36:!: 
0. 22 
24 . 74! 
14 . 65 
+ 1 .  72-
0 . 69 
1Avera.ge of three trials 
2Average of tvo trials 
3va.iue from only one trial 
treated 
* 
+ 7 - 51-
0 . 99 
+ 0 . 72-
0 . 17 
1 . 81± 
_Q_. 67 
+ 
0 . 25-
0 . 06 
27 . 90! 
12 . 52 l 
2 . 32:!: 
o . 44 1 
Plasma. 
( Ui.'1/100 ml ) 
control treated 
30 . 25� 23 . 04:t 
2 . 47 2 . 59 
+ 14 . 08- + 17 . 30-
2 . 13 4 . 72 
+ 
5 . 12- * 48+ 7 .  -
2 . 12 2 . 48 
+ + 44 . 55- 32 . 10-2 29 � 74 l 12 . 38 
Urine 
(uM/rat/24 hours ) 
control 
23 . 68! 
8 . 71 
+ 
0 . 39-
0 . 17 
11 . 06± 
4 . 47 
823 . 17! 
202 . 43 
4 . 42! 
2 . 20 1 
treated 
* 
31 . 21! 
7 . 67 
+ 
1 . 20-
0 . 23 
2 . 61! 
0 . 79 
705 . 04! 
134 . 17 
5 . 37:!: 
1 . 51 1 
f\) 
\J1 
The treatment did not appreciably affect the total ninhydrin­
color-reactive substances of the liver, plasma , or urine. It 
should be noted that the total color•-reactive substances in liver 
is based on grams of tissue and the total in urine is based on 24-
hour excretion. 
Of the changes observed in the individual amino acid concen­
trations, the least effects were noted in the liver . Only a non­
amino acid, phosphoetha.nolamine, showed a consistent change , i . e .  
decrease, due to treatment. In the plasma increases were observed 
due to treatment for ornithine and taurine . Arginine , cystine , and 
valine showed consistent decreases .  The daily excretion of several 
amino acids in the urine of treated animals was increased. They 
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were glutamic acid, histidine, 1-methyl histidine, 3 -methyl histidine , 
leucine , lysine , ornithine , threonine, and ethanolamine . The 
urinary excretion of cystine and taurine was decreased by the treat­
ment. 
DISCUSSION 
The work indicates that· various metabolic changes may be 
produced in rats by short term treatment with a high level of 
selenium. A 4-day treatment caused liver enlargement accompanied 
by liver fat accumulation. The plasma lipid content was also 
elevated in most cases. Such  effects have not previously been 
reported in selenium toxicity (41 , 42 ) .  The treatment caused 
multiple changes in the amino acid composition of the blood plasma 
and urine, and a few changes in the liver tissue. It was also 
capable of temporarily inducing a complete restriction of voluntary 
feed consumption if the injected animals were fed ad li�it.lll'I! 
rather than force fed. Thus, it is evident that many effects of 
selenium toxicity can be studied with relatively short treatment 
periods. 
The increases in liver and plasma lipid may have been caused 
by increased mobili�ation of adipose depot fat as a result of the 
selenium toxicity. Hepatotoxins are known to increase the rate of 
adipose fat mobilization a.nd thus cause liver fat accumulation. 
Increased mobilization is generally accompanied by increased free 
fatty acid levels in the blood (43 ) .  However, in the present studies 
increased levels of plasma f"ree fatty acids appeared in some trials 
and not in other trials. The increased levels might have been more 
marked if plasma samples had been obtained soon a:fter the selenium 
injection rather than following a 24-hour interim . 
27 
Fat accumulation in the liver ma_v also occur when this organ 
is  unable to adequately mobilize fat which it normally synthesizes 
( 43 ) . This response has been shown to occur during a choline de­
ficiency. Such a deficiency restricts phospholipid synthesis and 
subsequently restricts the rate at which fatty acids are dis- · 
charged from the liver as phosphatides ( 43). This mechanism is 
supported in the present studies by the decreased levels of two 
choline precursors, i. e. phosphoethanola.mine and ethanolamine , in 
livers of treated animals. Further , it is supported by the increase 
in the percentage of free fatty acids observed in the liver lipid , 
and the decreased levels of phospholipids observed in plasma in 
most cases. 
The amino acid effects obtained from treatment consisted of 
several definite changes with plasma and urine. In plasma, the 
concentration of ornithine was elevated by the treatment , and that 
of cystine, valine ,  and arginine was depressed. The non-amino acid , 
taurine, was also increased due to treatment. While two of these 
amino acids , ornithine and arginine, are involved in the formation 
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of urea in the liver , the present data do not support the possibility 
that selenium toxicity may interfere with urea synthesis since the 
concentration of urea was not changed in either plasma or urine due 
to treatment. 
The large decrease of valine in plasma is of particular 
interest. Such a plasma deficiency of  this essential amino acid 
might cause a lowering of protein synthesis within the animal and 
thereby cause metabolic disturbances (44 ) .  The lowering of plasma 
cystine was also of interest. Although cystine is a nonessential 
amino acid , it is known to be associated with certain metabolites 
within the animal. One of these is glutatione which is active in 
oxidation-reduction reactions (43, p. 360). A role of cystine in 
the prevention of liver necrosis in the rat is also recognized 
(43 , p. 935). 
Little is known about the significance of taurine in the 
animal body so it is difficult to postulate a relationship to the 
toxicity response. However , since the increased plasma levels of 
taurine were accompanied by reduced excretion of taurine in the . 
urine the effect may have been caused by a defect in excretion which 
caused higher levels to remain in the plasma . 
It is noteworthy that a considerable elevation of urinary 
amino acid excretion occurred due to the treatment. The increases 
amounted to as much as 90% with some amino acids. Such an effect 
reflects elevated losses of metabolites from the animal. Whether 
these increases might be related to kidney function or to temporary 
increases of amino acids in the blood is not known. The extent of 
tubular reabsorption may significantly influence the excretion of 
29 
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amino acids , but the chemical details of this process are not yet 
understood. If the concentrations of amino acids in the blood are 
elevated an "over-flow" may occur into the urine (44  p. 1030) . 
However, only one amino acid , ornithine , showed an increase in the 
plasma at the time of sampling. It is of interest to speculate that 
additional plasma amino acids might have been determined to be 
elevated by treatment if the sampling procedure had been more com­
parable to that used with urine . In the case  of urine the samples 
represented a 24-hour collection which began at the time of injection. 
The plasma samples were collected 24 hours after the last injection. 
It is possible that amino acid analogues formed in selenium 
metabolism might have caused interference in the amino acid analysis. 
It has been reported that selenomethionine and selenocystine have 
the same elution patterns with the Beckman amino acid analyser as 
leucine and methionine, respectively (4 5 ). Because the average con­
centration of both leucine and methionine was slightly higher in 
the liver, plasma, and urine of the treated animals, the pos sibility 
that the leucine and methionine peaks were contaminated is evident. 
It would be possible to verify this . with the use of labeled selenium. 
SUMMARY 
The effect of selenium toxicity on the lipid and amino acid 
metabolism in the rat has been s tudied . 
Eight week old, female, albino rats were inj ected daily 
during 4 days with 0. 8 milligrams s elenite-Se per kilogram of body 
weight. Control animals received distilled water injections . All 
animals were fed the s ame amount of liquid diet by force-feeding 
methods during the 4-day treatment. Twenty four hours following 
the final injection liver and plasma samples were obtained from 
the animals. Urine samples were collected during two , 24 hour 
periods prior to sacrifice. Significant liver enlargement had 
occurred in the treated animals by the time of sacrifice . 
The toxic treatment caused the average liver lipid concen­
tration to increase by 12% in the treated. animals, and the plasma 
lipid to increase by 3-49% in four of five trials . Of the indi­
vidual lipid components an effect of interest was the elevation of 
liver free fatty acids.  In some instances plasma free fatty acids 
were elevated and phospholipids were decreased . 
With the amino acids and certain related compounds treatment 
caused a decreas e  in liver phosphoethanolemine ,  in plasma arginine , 
cystine , and valine, and in urinary excretion of cystine and taurine. 
There were increased levels of plasma ornithine and taurine in 
treated animals �  and urinary excretion of glutamic acid, histidine , 
31 
1-methyl histidine, 3-methyl histidine, leucine, lysine , ornithine , 
threonine, and ethanolamine was increased by 40-90%. 
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APPENDIX 
The reflectometry procedure used for quantitative lipid 
analysis in this laboratory has not been previously recorded , thus , 
further information concerning the reproducibility of the results 
which were obtained is reported in Table 6. The plasma lipid 
samples from trial 4 were applied to three different thin-layer 
chromatograms and a comparison was made between the results ob­
tained from each plate. The samples were applied in triplicate 
on each chromatogram along with three concentrations of the 
standard lipid solution. For the triglyceride and free fatty acid 
determination 200 micrograms of the unknown total lipid were applied 
for each separation. In the case of triglycerides the average values 
for the control animals from each of the plates were 5. 7 ,  7. 5 ,  and 
6 . 7  micrograms of triglyceride per 100 micrograms of total lipid . 
For the treated animals , the values were 8. 6 ,  9. 9 ,  and 8. 7 micro­
grams. Thus, some variation did occur between the plates . However , 
the results showed a higher percentage of triglyceride in the 
treated animals in each case. The free fatty acid analysis showed 
5. 5, 7 . 0, and 7. 1 milligrams per 100 milligrams total lipid, and 
the control group had 5. 0, 6. 6 ,  and 4. 6 milligrams per 100 milli­
grams lipid. Two chromatoplates were prepared for cholesterol 
determination and the results were 14. o a.nd 10. 0 milligrams for 
the control animals and 16. 2 and 13. 2 milligrams for the treated 
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animals per 100 milligrams of total lipid. The values obtained 
for cholesterol esters were 31 . 2 ,  38. 5 ,  and 35. 0 milligrams per 100 
milli�rams of lipid for the control group and 29. 8 ,  27. 7, and 32. 7 
milligrams for the treated group. 
These data show that some variation does occur between the 
results obtained from one plate to a.nether with the same sample , 
but the differences  are generally small. It is also noted that the 
relationship between the treated and control groups is always the 
same between plates , for example , each determination shows that 
both triglycerides and free fatty acids are higher in the case of 
the treated animals as compared to control animals . Thus , thi. s 
method provided a good analytical tool for studying treatment 
effects on lipid concentrations although it may not be precisely 
quantitative in every instance . 
Table 6 .  Comparison of Lipid Component Analysis on Tr...ree Chromatograms 
Micrograms standard 
or unknown ap�lied 
to chromatogram 
Standard 
triolien 10 . 0  
15 . 0  
20 . 0 
Unknown 
control 200. 0 
200 . 0 
200 . 0  
treated 200 . 0 
Standard 
200 . 0 
200 . 0  
oleic acid 10. 0  
15 . 0  
20 . 0  
Optical density 
-�hr�matogr�_ 
1 2 3 
0 .�02 O . l02 0 . 111 
o . i12 0. 122 0 . 128 
0 . 149 0 . 155  0. 167 
0 . 111 0 . 125 0 . 119  
0 . 100 0 . 125 0 . 131 
0. 108 0 . 128 0 . 122 
0 . 134 0. 152 0. 158 
0 . 140 0 . 156 0 . 149 
0 . 134 0 . 156 0 . 149 
0 . 058 0 . 058 0 . 081 
0 . 076 0 . 089 0 . 100 
0 . 100 0 . 125 0 . 125 
Average 
Average 
Micrograms component 
per 100 micrograms 
total liuid 
chromatogram 
1 2 3 
Tt"�glyceride_ 
6 . 2  7. 2 6 . o  
5 . O 7 .· 2 7 .  5 
-�Q _ 8 .  o . 6 � 
5 . 7 7 . 5  b. 7 
8 . 2  9 - 7  9 . 0 
8 . 7  10 . 0  8 . 5  
8 . 2  10 . 0  8 . 5  
8 . 6  . 9 . 9  8 . 7  
Free_ fatty�_ Acids 
w 
C, 
__ chrom�togram 
1 2 3 
Unknown 
control 200 . 0 0 . 058 0 . 081 0 . 071 
200 . 0 0 . 058 0 . 078 0 . 081 
200 . 0  0 . 058 0 . 078 0 . 076 
treated 200. 0 0 . 060 0. 082 0. 091 
200. 0 0 . 061 0 . 083 0. 098 
200. 0 0 . 060 0 . 083 0. 100 
Standard 
cholesterol 
10 . 0  0 . 053 0 . 053 
15 . 0  0 . 063 0. 065 
20 . 0  0 . 089 0 . 076 
Unknown 
control 100. 0 0 . 068 0 . 053 
100. 0 0 . 055  0. 048 
100. 0 0 . 071 0 . 0 55 
treated 100 . 0  0 . 071 0 . 058 
100 . 0  0 . 071 0 . 060 
100. 0 0 . 073 0 . 060 
Average 
Average 
Averafl,e 
Avera.;r,e 
chromatog_r� 
1 2 3 
5 . 0  6 . 7  4 . o  
5. 0 6 . 5 5 . 0  
5 . 0  6 . 5 4 . 7 
-S:6 -b.b 4� 
5 . 5  6 . 9 6. 5 
5 . 5  1 . 0 7 . 2  
.. 5 . 5 7 . 0 _ 7 . 5  
5 . 5 7. 0 7 . 1 
Cholesterol 
15 . 0  10 . 0  
. 11 . 0 9. 0 
16 . 0  11 . 0  
i4:0 10.6  
16 . 0  12 . 5  
16 . 0  13 . 5  
16 . 5  13. 5 
i6 � 13 . 2  
w 
'-0 
Cholesterol 
oleate 10 . 0  
15 . 0  
20 . 0  
25 . 0  
30 . 0  
35. 0  
Unknown 
control 100 
100 
100 
treated 100 
100 
100 
chromato�ram 
1 2 3 
0 . 105 0 . 105 
0 . 122 0 . 122 
0. 134 0. 143 0 . 14 0  
0 . 152 
0 . 171 
0 . 211 
0 . 171 0 . 222 0 . 190 
0 . 184 0 . 211 0 . 211 
0 . 174 0 . 211 
0 . 164 0. 171 0. 190 
0 . 194 0 . 171 0 . 183 
0 . 184 0 . 174 
Average 
Average 
chromatogram 
1 2 3 
Cholesterol Esters 
30 . 0  40 . 5  32. 5 
33 . 0 37 . 5  37 . 5  
30 . 5  37 . 5 
31 . 2· 38 . 5  35. 0 
26. 0 27 . 5  37 . 5  
33. 0 27 . 5  30. 5 
30 . 5  2s . o  
29 . 8 27 : 1 32 �y 
+ 
0 
